Articles |

Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. FREE TO VIEW

J L Vincent; J Bakker; G Marécaux; L Schandene; R J Kahn; E Dupont
Chest. 1992;101(3):810-815. doi:10.1378/chest.101.3.810
Text Size: A A A
Published online


In this pilot study, murine monoclonal anti-TNF antibody (2 mg/kg) was administered to ten patients within 24 h of septic shock which persisted after initial resuscitation with intravenous fluids and adrenergic agents. This treatment resulted in a reduction in heart rate (from 122 +/- 10 to 113 +/- 10 beats per minute at 4 h, p less than 0.01) associated with an increase in LVSWI (from 26.5 +/- 5.6 to 31.5 +/- 10.5 g.m2 at 2 h, p less than 0.05), indicating in the absence of change in cardiac filling pressures, an improvement in ventricular function. Arterial oxygenation improved concurrently in six patients. These changes, however, appeared transient. The improvement in cardiac function following anti-TNF antibody administration in patients is in keeping with recent experimental studies indicating the role of TNF in the myocardial depression characterizing septic shock.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Genetic Polymorphisms in Sepsis and Septic Shock*: Role in Prognosis and Potential for Therapy
Cardiac Inflammation and Innate Immunity in Septic Shock*: Is There a Role for Toll-Like Receptors?
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543